681 related articles for article (PubMed ID: 27873103)
21. Urokinase-type Plasminogen Activator (uPA) Promotes Angiogenesis by Attenuating Proline-rich Homeodomain Protein (PRH) Transcription Factor Activity and De-repressing Vascular Endothelial Growth Factor (VEGF) Receptor Expression.
Stepanova V; Jayaraman PS; Zaitsev SV; Lebedeva T; Bdeir K; Kershaw R; Holman KR; Parfyonova YV; Semina EV; Beloglazova IB; Tkachuk VA; Cines DB
J Biol Chem; 2016 Jul; 291(29):15029-45. PubMed ID: 27151212
[TBL] [Abstract][Full Text] [Related]
22. Differential role of beta-catenin in VEGF and histamine-induced MMP-2 production in microvascular endothelial cells.
Doyle JL; Haas TL
J Cell Biochem; 2009 May; 107(2):272-83. PubMed ID: 19306293
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of Single Routes of Intracellular Signaling is Not Sufficient to Neutralize the Biphasic Disturbance of a Retinal Endothelial Cell Barrier Induced by VEGF-A165.
Deissler HL; Lang GK; Lang GE
Cell Physiol Biochem; 2017; 42(4):1493-1513. PubMed ID: 28719888
[TBL] [Abstract][Full Text] [Related]
24. Claudin-5 controls intercellular barriers of human dermal microvascular but not human umbilical vein endothelial cells.
Kluger MS; Clark PR; Tellides G; Gerke V; Pober JS
Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):489-500. PubMed ID: 23288152
[TBL] [Abstract][Full Text] [Related]
25. The impact of the receptor binding profiles of the vascular endothelial growth factors on their angiogenic features.
Nieminen T; Toivanen PI; Rintanen N; Heikura T; Jauhiainen S; Airenne KJ; Alitalo K; Marjomäki V; Ylä-Herttuala S
Biochim Biophys Acta; 2014 Jan; 1840(1):454-63. PubMed ID: 24112971
[TBL] [Abstract][Full Text] [Related]
26. Glycogen-Synthase Kinase3beta/beta-catenin axis promotes angiogenesis through activation of vascular endothelial growth factor signaling in endothelial cells.
Skurk C; Maatz H; Rocnik E; Bialik A; Force T; Walsh K
Circ Res; 2005 Feb; 96(3):308-18. PubMed ID: 15662032
[TBL] [Abstract][Full Text] [Related]
27. Pro-angiogenic activity of notoginsenoside R1 in human umbilical vein endothelial cells in vitro and in a chemical-induced blood vessel loss model of zebrafish in vivo.
Yang BR; Hong SJ; Lee SM; Cong WH; Wan JB; Zhang ZR; Zhang QW; Zhang Y; Wang YT; Lin ZX
Chin J Integr Med; 2016 Jun; 22(6):420-9. PubMed ID: 25533511
[TBL] [Abstract][Full Text] [Related]
28. Endothelial Gαq/11 is required for VEGF-induced vascular permeability and angiogenesis.
Sivaraj KK; Li R; Albarran-Juarez J; Wang S; Tischner D; Grimm M; Swiercz JM; Offermanns S; Wettschureck N
Cardiovasc Res; 2015 Oct; 108(1):171-80. PubMed ID: 26272756
[TBL] [Abstract][Full Text] [Related]
29. Novel role of ARF6 in vascular endothelial growth factor-induced signaling and angiogenesis.
Ikeda S; Ushio-Fukai M; Zuo L; Tojo T; Dikalov S; Patrushev NA; Alexander RW
Circ Res; 2005 Mar; 96(4):467-75. PubMed ID: 15692085
[TBL] [Abstract][Full Text] [Related]
30. A BMP7 Variant Inhibits Tumor Angiogenesis In Vitro and In Vivo through Direct Modulation of Endothelial Cell Biology.
Tate CM; Mc Entire J; Pallini R; Vakana E; Wyss L; Blosser W; Ricci-Vitiani L; D'Alessandris QG; Morgante L; Giannetti S; Larocca LM; Todaro M; Benfante A; Colorito ML; Stassi G; De Maria R; Rowlinson S; Stancato L
PLoS One; 2015; 10(4):e0125697. PubMed ID: 25919028
[TBL] [Abstract][Full Text] [Related]
31. Hypoxia paradoxically inhibits the angiogenic response of isolated vessel explants while inducing overexpression of vascular endothelial growth factor.
Aplin AC; Nicosia RF
Angiogenesis; 2016 Apr; 19(2):133-46. PubMed ID: 26748649
[TBL] [Abstract][Full Text] [Related]
32. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
33. Vitronectin regulation of vascular endothelial growth factor-mediated angiogenesis.
Li R; Luo M; Ren M; Chen N; Xia J; Deng X; Zeng M; Yan K; Luo T; Wu J
J Vasc Res; 2014; 51(2):110-7. PubMed ID: 24603119
[TBL] [Abstract][Full Text] [Related]
34. Sulfated fucoidan FP08S2 inhibits lung cancer cell growth in vivo by disrupting angiogenesis via targeting VEGFR2/VEGF and blocking VEGFR2/Erk/VEGF signaling.
Chen H; Cong Q; Du Z; Liao W; Zhang L; Yao Y; Ding K
Cancer Lett; 2016 Nov; 382(1):44-52. PubMed ID: 27569654
[TBL] [Abstract][Full Text] [Related]
35. Notoginsenoside Ft1 promotes angiogenesis via HIF-1α mediated VEGF secretion and the regulation of PI3K/AKT and Raf/MEK/ERK signaling pathways.
Shen K; Ji L; Gong C; Ma Y; Yang L; Fan Y; Hou M; Wang Z
Biochem Pharmacol; 2012 Sep; 84(6):784-92. PubMed ID: 22771629
[TBL] [Abstract][Full Text] [Related]
36. Vascular endothelial growth factor activation of sterol regulatory element binding protein: a potential role in angiogenesis.
Zhou RH; Yao M; Lee TS; Zhu Y; Martins-Green M; Shyy JY
Circ Res; 2004 Sep; 95(5):471-8. PubMed ID: 15271857
[TBL] [Abstract][Full Text] [Related]
37. Rosiglitazone increases endothelial cell migration and vascular permeability through Akt phosphorylation.
Ku YH; Cho BJ; Kim MJ; Lim S; Park YJ; Jang HC; Choi SH
BMC Pharmacol Toxicol; 2017 Aug; 18(1):62. PubMed ID: 28854981
[TBL] [Abstract][Full Text] [Related]
38. Endothelial HNF4α potentiates angiogenic dysfunction via enhancement of vascular endothelial growth factor resistance in T2DM.
Chai X; Yan J; Gao Y; Jin J
J Cell Biochem; 2019 Aug; 120(8):12989-13000. PubMed ID: 30873661
[TBL] [Abstract][Full Text] [Related]
39. Salinomycin exhibits anti-angiogenic activity against human glioma in vitro and in vivo by suppressing the VEGF-VEGFR2-AKT/FAK signaling axis.
Bi YL; Mi PY; Zhao SJ; Pan HM; Li HJ; Liu F; Shao LR; Zhang HF; Zhang P; Jiang SL
Int J Mol Med; 2017 May; 39(5):1255-1261. PubMed ID: 28358414
[TBL] [Abstract][Full Text] [Related]
40. Pigment epithelium-derived factor inhibits vascular endothelial growth factor-and interleukin-1beta-induced vascular permeability and angiogenesis in retinal endothelial cells.
Sheikpranbabu S; Ravinarayanan H; Elayappan B; Jongsun P; Gurunathan S
Vascul Pharmacol; 2010; 52(1-2):84-94. PubMed ID: 20006737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
